Rebetol (ribavirin)

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HepacivirusHepatitis CHepatitis C, Chronic

Phase 3

The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)

TerminatedNCT00441584

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2005-07-31End: 2008-06-30Updated: 2017-04-05

Unknown Phase

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

CompletedNCT00724464

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2007-12-31End: 2010-10-31Updated: 2015-10-19

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

CompletedNCT00723892

Merck Sharp & Dohme LLCHepacivirus, Hepatitis C, Chronic

Start: 2005-07-31End: 2009-05-31Updated: 2015-10-30

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

CompletedNCT00725205

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2006-03-31End: 2010-10-31Updated: 2015-10-08